TRIPTOLIDE INHIBITS MCP-10VERPRODUCTION IN HUMAN PROXIMAL TUBULAR CELLS INDUCED BYIFNγ AND TNFα COSTIMULATION

Zhihong LIU,Chunsun DAI,Heng LI,Dong LIU,Hong LIU,Leishi LI
DOI: https://doi.org/10.3969/j.issn.1006-298X.2000.05.008
2000-01-01
Abstract:OBJECTIVE To investigate the effects of triptolide in inhibiting the MCP-1 production in human proximal tubular cells METHODOLOGY A human proximal tubular cell line was selected. A combination of IFN-γ(200 μg/L)and TNFα(20 μg/L)was used to stimulate the production of MCP-1 in tubular cells. Intracellular MCP-1 was detected by flowcytometry and MCP-1 inthe supematant was measured by "sandwich" ELISA method. MCP-1 mRNA expression was detected by semi-quantitative poly-merase chain reaction. RESULTS In unstimulated tubular cells, a mild of MCP-1 was detected in cells and in culture super-natants. In the supernatants of tubular cells costimulated with IFN-γ(200 μg/L)and TNFα(20 μg/L) for 24 hours, MCP-1 produc-tion was significantly increased (1120.9±71.9 vs 141.9±17.3 ng/L·μg protein-1, P<0.01), a similar increase of intracellularMCP-1 protein was observed with FACS analysis. MCP-1 mRNA expression was increased nearly two folds of that in unstimulated cells. Triptolide could dose-dependently inhibit MCP-1 protein production(713.1±28.4 vs 1120.9±71.9 ng/L·μg protein-1, P< 0.01 )and mRNA expression stimulated by inflammatory factors. CONCLUSION Triptolide can inhibit MCP-1 overproduc-tion in human tubular cells induced by IFN-γ(200 μg/L)and TNFα(20 μg/L)costimulation. This may be one of the mechanisms bywhich triptolide excerts in treatment of renal diseases.
What problem does this paper attempt to address?